You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CRSP Exercise Disclosure
Kasinger James R. · SEC Form 4 · Filed Sep 24, 2026
Exercise
Calculated transaction value
$0
Kasinger James R. General Counsel And Secretary
CRSP
Transaction date
Sep 22, 2026
Public filing date
Sep 24, 2026
Filing lag
Filed 2 days later
CRSP daily price context
Close on/before transaction
$59.03
Sep 22, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Shares
- Quantity / price
- 10,400 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-401237
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$768.11K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crispr Therapeutics Ag CRSP | Exercise | Sep 22, 2026 | $141.65K |
| Crispr Therapeutics Ag CRSP | Sale | Sep 22, 2026 | $626.46K |
| Crispr Therapeutics Ag CRSP Current | Exercise | Sep 22, 2026 | $0 |